A Delaware Warrant Agreement is a legal contract created between A.L. Pharma, Inc., and The First National Bank of Boston regarding the issuance of warrants. Warrants are financial instruments that provide the holder with the right to purchase a specific number of shares of a company's stock at a predetermined price within a defined time period. This agreement outlines the terms and conditions under which these warrants are issued and exercised. The Delaware Warrant Agreement between A.L. Pharma, Inc., and The First National Bank of Boston may come in different types, categorized based on specific features or purposes. Some key types of warrant agreements include: 1. Standard Warrant Agreement: This is the basic form of warrant agreement, defining the terms and conditions for the issuance and exercise of warrants. It includes details such as the exercise price, expiration date, and the number of shares that can be purchased. 2. Cashless Exercise Warrant Agreement: This type of agreement allows the warrant holder to exercise their warrants without using cash. Instead, the exercise price is deducted from the value of the underlying shares. 3. Anti-Dilution Warrant Agreement: This agreement includes provisions that protect warrant holders from future dilution of their ownership stakes. It may provide for adjustments to the exercise price or the number of shares available for purchase in the event of stock splits, dividends, or other similar corporate actions. 4. Standby Warrant Agreement: This agreement is often used in conjunction with a rights offering or other financing arrangements. The First National Bank of Boston agrees to purchase any exercised warrants at a specified price if they are not exercised by other shareholders. 5. Registration Rights Warrant Agreement: This type of agreement provides the warrant holder with the right to demand registration of the underlying shares with the Securities and Exchange Commission (SEC). It ensures that the warrant holder can freely sell the shares in the public market. The Delaware Warrant Agreement between A.L. Pharma, Inc., and The First National Bank of Boston is a legally binding document that protects the rights and interests of both parties. It establishes clear guidelines for the issuance, exercise, and transferability of warrants, promoting transparency and efficiency in the warrant transaction process.